|
1. Name of the securities: CHINA CHEMICAL & PHARMACEUTICAL CO., LTD.
2. Trading date: 2018/10/01
3. Trading volume, unit price, and total monetary amount of the transaction:
Unit price: No more than NT$30 per share;
Total monetary amount: No more than NT$ 250,000,000
4. Gain (or loss) (not applicable in case of acquisition of securities): NA
5. Relationship with the underlying company of the trade:
CCSB is the Company's investment using the equity method of accounting.
6. Current cumulative volume, amount, and shareholding percentage of holdings of the security being traded (including the current trade) and status of any restriction of rights (e.g.pledges):
The actual transaction information will be announced in accordance with the provisions of Regulations Governing the Acquisition and Disposal of Assets by Public Companies .
7. Current ratio of long or short term securities investment (including the current trade) to the total assets and shareholder's equity as shown in the most recent financial statement and the operational capital as shown in the most recent financial statement:
Ratio to the total assets and shareholder's equity: The actual transaction information will be announced in accordance with the provisions of Regulations Governing the Acquisition and Disposal of Assets by Public Companies .
The operational capital as shown in the most recent financial statement: NT$ 157,475 thousand
8. Concrete purpose/objective of the acquisition or disposal: Investment
9. Do the directors have any objections to the present transaction?: No
10. Any other matters that need to be specified:
The actual transaction information will be announced in accordance with the
provisions of Regulations Governing the Acquisition and Disposal of Assets by Public
Companies.
|
